Hypertension Trial, Recruiting NCT05545501 Sponsor: Indiana University Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT05545501
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between the ages of 19 and 39.
  • People whose resting blood pressure is no higher than 150/90.
  • People with a Body Mass Index (BMI, a measure of body weight relative to height) below 35, or who are otherwise in good general health (confirm with trial site).
  • People who have no history of metabolic conditions such as diabetes or kidney disease, no lung conditions such as COPD, severe asthma, or cystic fibrosis, and no heart or blood vessel conditions.
  • People who are able to exercise safely and are able to give a blood sample without medical concerns.

Who may not be able to join:

  • People with high blood pressure above 150/90 mmHg.
  • People with a BMI over 30 (a common measure used to classify obesity).
  • People with a history of diabetes or kidney disease, lung conditions such as COPD, severe asthma, or cystic fibrosis, or heart and blood vessel conditions.
  • People with a medical condition that makes exercise unsafe, such as heart problems or painful joint conditions like arthritis.
  • People with a medical condition that prevents giving blood safely, such as taking blood-thinning medication.
  • People who have smoked, used smokeless tobacco, or vaped at any point in the past 12 months.
  • People who are currently pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Austin T Robinson, PhD, Indiana University

Phone: 5745141034

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 March 2023
Est. completion
31 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Resting blood pressure; Blood pressure reactivity responses

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov